Results
    Type
    Region
    Country of origin
    Qualifications

    Decitabine | compare suppliers & send inquiries for free

    Here you will find a list of producers, manufacturers and traders of Decitabine. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
    Taiwan Scinopharm
    Type: Producer
    Produced in: Taiwan
    Taiwan
    India Shilpa Medicare
    Type: Producer
    Produced in: India
    India
    India Reliance Life Sciences
    Type: Producer
    Produced in: India
    India
    China Zhejiang Hisun Pharma
    Type: Producer
    Produced in: China
    China
    China Wuhan Calmland 
    Type: Producer
    Produced in: China
    China
    United Kingdom Intas Pharma
    Type: Producer
    Produced in: United Kingdom
    Unknown
    India Fresenius Kabi Onc.
    Type: Producer
    Produced in: India
    India
    China Qilu Pharma
    Type: Producer
    Produced in: China
    China
    China Jiangsu Hansoh Pharma
    Type: Producer
    Produced in: China
    China
    India Sionc Pharma
    Type: Producer
    Produced in: India
    India
    India Biophore India
    Type: Producer
    Produced in: India
    India
    India MSN Labs.
    Type: Producer
    Produced in: India
    India
    India Dr. Reddy's
    Type: Producer
    Produced in: India
    India
    India Emcure Pharma
    Type: Producer
    Produced in: India
    India

    Looking for Decitabine 2353-33-5?

    API | Excipient name:
    Decitabine 
    Synonyms:
    Azadc, Decitabine, Dezocitidine  
    Cas Number:
    2353-33-5 
    DrugBank number:
    DB01262 
    Unique Ingredient Identifier:
    776B62CQ27

    About Decitabine

    More information about the use of: Decitabine. Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic neoplasms with variable underlying etiology and presentation, including neutropenia and thrombocytopenia. Further mutations leading to increased proliferation of cancerous cells can eventually lead to secondary acute myeloid leukemia, which has a poor prognosis Among treatment options, nucleoside analogues such as decitabine and azacitidine integrate into cellular DNA and inhibit the action of DNA methyltransferases, leading to global hypomethylation and related downstream therapeutic benefits Decitabine was developed by MGI Pharma/SuperGen Inc. and was approved by the FDA for the treatment of MDS on February 2006.

    It was first marketed under the name Dacogen®.

    More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.

    Decitabine manufacturers | traders | suppliers
    We have 14 companies offering Decitabine from 4 different countries.

    Get in contact with the supplier of your choice:

    • MSN Labs. from India
    • Shilpa Medicare from India
    • Emcure Pharma from India
    • Zhejiang Hisun Pharma from China
    • Dr. Reddy's from India
    • Scinopharm from Taiwan
    • Reliance Life Sciences from India
    • Fresenius Kabi Onc. from India
    • Biophore India from India
    • Sionc Pharma from India
    • Qilu Pharma from China
    • Jiangsu Hansoh Pharma from China
    • Intas Pharma from United Kingdom
    • Wuhan Calmland  from China

    Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

    You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.